openPR Logo
Press release

A Deep Dive into Remicade Market 2025: Key Drivers, Growth Factors, and Projections 2025-2034

02-18-2025 12:25 PM CET | Health & Medicine

Press release from: The Business Research Company

Remicade Market Size

Remicade Market Size

How Will the Remicade Market Grow, and What Is the Projected Market Size?
The remicade market has seen substantial growth in the past few years. The market size is expected to increase from $2514.05 million in 2024 to $2656.87 million in 2025, with a compound annual growth rate (CAGR) of 5.7%. The progression in the historical period can be credited to factors such as the occurrence of autoimmune diseases, greater acceptance and use of biologic therapies, advancements in healthcare infrastructure, patent exclusivity duration, and proven clinical effectiveness.

The market size of remicade is projected to witness robust growth in the forthcoming years. The growth is estimated to reach $3268.05 million in 2029, with a compound annual growth rate (CAGR) of 5.3%. Several factors contributing to the growth in the forecasted period include an increasing prevalence of biosimilars, worldwide disease load, an expanding market in emerging economies, regulatory and insurance assistance, and a rise in disposable income. Key trends anticipated during this period incorporate the acceptance of biosimilars, the assimilation of digital health, personalized medical treatment, innovative biologic therapies, and advancements in drug delivery systems.

What Key Elements Are Boosting Growth in the Remicade Market?
The anticipated growth of the remicade market is predicted to be largely driven by an increase in autoimmune diseases. These diseases occur when the body's immune system erroneously attacks its own healthy cells, tissues, or organs, perceiving them as outside threats. The escalating frequency of autoimmune illnesses could be linked to a combination of genetic susceptibility, changes in the environment, more exposure to pollution, lifestyle-related issues, and increased awareness in diagnostics. Remicade, or infliximab, is deployed to manage autoimmune diseases by focusing on and inhibiting the tumor necrosis factor-alpha (TNF-a), a significant inflammatory cytokine involved in conditions such as rheumatoid arthritis, Crohn's disease, and ulcerative colitis. As per data from the Centers for Disease Control and Prevention (CDC) released in February 2024, in 2022, the age-standardized prevalence of diagnosed arthritis in adults 18 years and older stood at 18.9%, with the condition being more prevalent in women (21.5%) than men (16.1%). The incidence of arthritis showed an increase with age, starting from 3.6% in people aged 18-34 to 53.9% in those aged 75 and above. Consequently, the growing incidence of autoimmune diseases acts as a catalyst for the remicade market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20194&type=smp

Who Are the Major Industry Players Fueling Remicade Market Expansion?
Major companies operating in the remicade market include Janssen Biotech Inc.

What Are the Emerging Trends in the Remicade Industry?
The rising focus on innovative drug formulation is a noteworthy trend in the Remicade market, particularly the creation of subcutaneous medications. This not only enhances patient comfort but also boosts treatment adherence, and broadens market accessibility, providing a quicker and simpler substitute to conventional intravenous therapies. For instance, US-based biopharmaceutical firm, Celltrion USA, Inc., rolled out Zymfentra, which is the first subcutaneous formulation of infliximab that has been greenlit by the FDA, in March 2024. Zymfentra (infliximab-dyyb) is prescribed as a maintenance therapy for adults suffering from moderately to severely active ulcerative colitis (UC) and Crohn's disease (CD), both of which are recognized as inflammatory bowel disease (IBD). Post-treatment with an intravenous infliximab product, its approval permits its use, presenting a beneficial alternative for long-term disease handling.

How Is the Segmentation of the Remicade Market Defined?
The remicade market covered in this report is segmented -

1) By Disease Indication: Crohn's disease, Rheumatoid arthritis, Ankylosing spondylitis, Psoriatic arthritis, Ulcerative Colitis, Plaque psoriasis
2) By Route Of Administration: Subcutaneous, Intravenous, Parenteral
3) By End Use: Hospitals, Clinics, Ambulatory Care, Home Care

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/remicade-global-market-report

What Is the Leading Region in the Remicade Market?
North America was the largest region in the remicade market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the remicade market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What Is Covered In The Remicade Global Market Report?

- Market Size Analysis: Analyze the remicade Market Size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the remicade market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall remicade market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the remicade market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20194

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release A Deep Dive into Remicade Market 2025: Key Drivers, Growth Factors, and Projections 2025-2034 here

News-ID: 3874214 • Views:

More Releases from The Business Research Company

Robotic Arm Market Growth Driven By E-Commerce Demand For Material Handling Efficiency: A Key Catalyst Accelerating Robotic Arm Market Growth in 2025
Robotic Arm Market Growth Driven By E-Commerce Demand For Material Handling Effi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Robotic Arm Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The market size for robotic arms has seen a speedy expansion over the past years. Its value is projected to rise from $36.93 billion in 2024 to $42.63 billion in 2025, with a compound annual
Palletizer Market Expected to Achieve 4.5% CAGR by 2029: Growth Forecast Insights
Palletizer Market Expected to Achieve 4.5% CAGR by 2029: Growth Forecast Insight …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Palletizer Market Size By 2025? The market for palletizers has witnessed a consistent growth in the last few years. Its worth will increase from $2.72 billion in 2024 to $2.82 billion in 2025 with a compound annual growth rate (CAGR) of 3.7%. The growth during
Soaring Demand Set to Propel Packaging Automation Market to $120.43 Billion by 2029
Soaring Demand Set to Propel Packaging Automation Market to $120.43 Billion by 2 …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Packaging Automation Market Through 2025? The size of the packaging automation market has seen considerable growth lately. It is projected to escalate from $78.49 billion in 2024 to $85.41 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 8.8%. The
Emerging Trends to Drive Microchannel Heat Exchanger Market Growth at 8.4% CAGR Through 2029
Emerging Trends to Drive Microchannel Heat Exchanger Market Growth at 8.4% CAGR …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Microchannel Heat Exchanger Market Size Growth Forecast: What to Expect by 2025? In recent times, the microchannel heat exchanger market has seen significant growth. The market, valued at $14.22 billion in 2024, is predicted to increase to $15.31 billion by 2025, with a compound annual growth rate (CAGR) of

All 5 Releases


More Releases for Remicade

Surge In Autoimmune Diseases Fuels Remicade Biosimilar Market Growth Emerges as …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Remicade Biosimilar Market Through 2025? In recent times, we've seen significant expansion in the remicade biosimilar market. Projected growth from 2024's $3.95 billion to $4.89 billion in 2025 indicates a compound annual growth rate (CAGR) of 23.8%. This rise during the historic
Remicade Biosimilar Market Size, Trends, Analysis And Forecast 2024-2033
"The Business Research Company recently released a comprehensive report on the Global Remicade Biosimilar Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. Ready to Dive into Something Exciting? Get Your Free Exclusive Sample
Affordable Innovation: 2024 Global Market Report on Remicade Biosimilars
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033. Remicade Biosimilar Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance. The Market Size Is Expected To Reach $9.1 billion In 2028 At
Remicade Biosimilar Market Size & Growth Analysis Report, 2021-2027
Biosimilar can be defined as a type of biological product that is highly similar to an already FDA approved drug, known as reference biological product. (Get 15% Discount on Buying this Report) Get Sample Copy of Remicade Biosimilar Market at: https://www.orionmarketreports.com/remicade-biosimilar-2-market/48410/#ert_pane1-1 Segment by Type • 100mg/10ml • 500mg/50ml Segment by Application • Blood Disorders • Oncology Diseases By Company • Synthon Pharmaceuticals • LG Life Sciences • Novartis (Sandoz) • Celltrion • Biocon • Hospira • Merck Serono (Merck Group) • Biogen idec Inc A full report of Global Remicade Biosimilar Market is available at: https://www.orionmarketreports.com/remicade-biosimilar-2-market/48410/ Scope of the Report The research
Biosimilar of Remicade Market Is Thriving Worldwide
In a recent S&R Research publish Global Biosimilar of Remicade Market Insights, Forecast to 2025, analysts provide an in-depth analysis of the global market for Biosimilar of Remicade. By analyzing its historical and forecast data, the analysis analyzes the different aspects of the market. Some are part of the coverage and are the core and emerging players being profiled Synthon Pharmaceuticals, LG Life Sciences, Novartis (Sandoz), Celltrion, Biocon, Hospira, Merck
Remicade (Infliximab) Biosimilar Clinical Trial Insight
“Remicade (Infliximab) Biosimilar Clinical Trial Insight” report by PNS Pharma gives comprehensive clinical insight on 17 biosimilar version of Remicade drug in clinical pipeline. Currently there are 2 biosimilars in Phase-III trials and are expected to be commercially available in next 5-8 years. Currently 3 biosimilar version of Remicade are commercially available in India, Brazil and European countries for the treatment of Ankylosing spondylitis, Crohn's disease and Rheumatoid Arthritis. The